Pharmafile Logo

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202

 Latest Content from PMHub 

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Apex launches new immersive gastronomic event experience in the pharma sector

Specialist pharmaceutical conference and event management company Apex has launched the ultimate immersive gastronomic experience in the UK and global events market.

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

It’s all about the cake/lettuce balance

World Digestive Health Day (WDHD) is held every year on 29 May, so now is the perfect time to redress the nutrition balance

Nucleus Global launches Nucleus POLAR™, a state-of-the-art expert search engine and engagement management tool

Nucleus POLAR™ uses cutting-edge technology to enable rapid external expert identification, mapping and centralised engagement planning.

Lucid Group and Vivid Medical Communications make the cut at this year’s Communiqué awards

Lucid Group has been shortlisted for the Porterhouse Medical Group Award for Medical Consultancy of the Year award, illustrating once again the magic that Lucid brings to the industry.Vivid, a...

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.